Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
Rhea-AI Summary
Vanda Pharmaceuticals (Nasdaq: VNDA) announced its upcoming participation in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025. The event will take place in New York City on Wednesday, May 21, 2025. This conference provides an opportunity for Vanda to engage with investors and discuss their developments in the neurological and ophthalmological therapeutic areas.
Positive
- None.
Negative
- None.
News Market Reaction – VNDA
On the day this news was published, VNDA gained 3.61%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro--ophthalmology-summit-2025-302458143.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When is Vanda Pharmaceuticals (VNDA) participating in the Mizuho Neuro & Ophthalmology Summit 2025?
Where is the Mizuho Neuro & Ophthalmology Summit 2025 being held?
What type of meetings will VNDA participate in at the Mizuho Summit 2025?
What is the stock symbol for Vanda Pharmaceuticals?
